Neovasculogenic effect of 11,12-epoxyeicosatrienoic acid involves the Akt/eNOS signaling pathways in human endothelial progenitor cells

The 11,12-epoxy-eicosatrienoic acid (11,12-EET) is formed from arachidonic acid (AA) by cytochrome P450 2J2 (CYP 2J2) epoxygenase and function as an effector in blood vessels. Human endothelial progenitor cells (hEPCs), a preceding cell source for endothelial cells (ECs), involve in the vascular tissue repairing by postnatal neovasculogenesis. However, the effect of 11, 12-EET on hEPCs and neovasculogenesis is not well known. In the current study, we examined the function of 11, 12-EET in hEPCs-mediated neovasculogenesis by using tubular formation analysis, Western Blotting assay, immunofluorescence staining, flow cytometry analysis and zymogram analysis. The results suggest that 11, 12-EET significantly induces neovasculogenesis through the phosphorylation of phosphoinositide 3-kinase (PI3–K)/Akt, endothelial-nitric oxide synthase (e-NOS) and extracellular signal-regulated kinase 1/2 (ERK 1/2) signaling pathways. 11, 12-EET up-regulates the expression of cyclin D1, cyclin–dependent kinase 4 (CDK4) and nuclear factor kappa B (NF-κB) proteins. Moreover, 11, 12-EET augments the expression of VE-cadherin and CD31 proteins in hEPCs. 11, 12-EET also augmented Rac1/Rho A signaling cascades, cell migration and an up-regulation of matrix metalloproteinase (MMP) −2 and −9 proteins. These results demonstrate that 11, 12-EET exerts a significant function in the neovasculogenesis of hEPCs.

[1]  E. Friedrich,et al.  Differentiation potential and functional properties of a CD34‑CD133+ subpopulation of endothelial progenitor cells. , 2019, Molecular medicine reports.

[2]  K. Schröder,et al.  NADPH Oxidases in the differentiation of endothelial cells. , 2019, Cardiovascular research.

[3]  I. Marzi,et al.  11,12 and 14,15 epoxyeicosatrienoic acid rescue deteriorated wound healing in ischemia , 2019, PloS one.

[4]  A. Rosell,et al.  Revascularization and endothelial progenitor cells in stroke. , 2018, American journal of physiology. Cell physiology.

[5]  Saurabh Sharma,et al.  Endothelial Progenitor Cells as Molecular Targets in Vascular Senescence and Repair. , 2018, Current stem cell research & therapy.

[6]  Shuh Narumiya,et al.  Rho signaling research: history, current status and future directions , 2018, FEBS letters.

[7]  Erica B. Peters.  Endothelial Progenitor Cells for the Vascularization of Engineered Tissues. , 2017, Tissue engineering. Part B, Reviews.

[8]  Takeshi Tanaka,et al.  Cell‐Surface MMP‐9 Protein Is a Novel Functional Marker to Identify and Separate Proangiogenic Cells from Early Endothelial Progenitor Cells Derived from CD133+ Cells , 2016, Stem cells.

[9]  E. Nagata,et al.  Recent Progress in Endothelial Progenitor Cell Culture Systems: Potential for Stroke Therapy , 2016, Neurologia medico-chirurgica.

[10]  B. Yao,et al.  Effects of dihydrotestosterone on adhesion and proliferation via PI3-K/Akt signaling in endothelial progenitor cells , 2014, Endocrine.

[11]  A. Piekny,et al.  Microtubules and actin crosstalk in cell migration and division , 2014, Cytoskeleton.

[12]  T. Crombleholme,et al.  The Role of Endothelial Progenitor Cells in Postnatal Vasculogenesis: Implications for Therapeutic Neovascularization and Wound Healing. , 2013, Advances in wound care.

[13]  Hau D. Le,et al.  Epoxyeicosanoids promote organ and tissue regeneration , 2013, Proceedings of the National Academy of Sciences.

[14]  Ping Li,et al.  Cytochrome P450 2J2: distribution, function, regulation, genetic polymorphisms and clinical significance , 2013, Drug metabolism reviews.

[15]  Zhongwei Lv,et al.  Downregulation of MicroRNA-130a Contributes to Endothelial Progenitor Cell Dysfunction in Diabetic Patients via Its Target Runx3 , 2013, PloS one.

[16]  Hong Wang,et al.  Rosuvastatin Enhances Angiogenesis via eNOS-Dependent Mobilization of Endothelial Progenitor Cells , 2013, PloS one.

[17]  Alan Hall,et al.  Rho family GTPases. , 2012, Biochemical Society transactions.

[18]  Donald E Ingber,et al.  Epoxyeicosanoids stimulate multiorgan metastasis and tumor dormancy escape in mice. , 2012, The Journal of clinical investigation.

[19]  J. Y. Kim,et al.  Direct and differential effects of stem cell factor on the neovascularization activity of endothelial progenitor cells. , 2011, Cardiovascular research.

[20]  I. Haviv,et al.  Successful In Vitro Expansion and Differentiation of Cord Blood Derived CD34+ Cells into Early Endothelial Progenitor Cells Reveals Highly Differential Gene Expression , 2011, PloS one.

[21]  Jianying Ma,et al.  [Changes of circulating endothelial progenitor cells in patients with coronary heart diseases before and after percutaneous coronary intervention]. , 2010, Zhonghua xin xue guan bing za zhi.

[22]  T. Holland-Letz,et al.  The CYP2J2 G-50T polymorphism and myocardial infarction in patients with cardiovascular risk profile , 2008, BMC cardiovascular disorders.

[23]  J. Falck,et al.  Epoxyeicosatrienoic acids are part of the VEGF-activated signaling cascade leading to angiogenesis. , 2008, American journal of physiology. Cell physiology.

[24]  F. Tang,et al.  Green tea catechin inhibits ephrin-A1-mediated cell migration and angiogenesis of human umbilical vein endothelial cells. , 2007, The Journal of nutritional biochemistry.

[25]  J. Falck,et al.  Mechanisms by which epoxyeicosatrienoic acids (EETs) elicit cardioprotection in rat hearts. , 2007, Journal of molecular and cellular cardiology.

[26]  Wan-Wan Lin,et al.  High glucose-induced apoptosis in human vascular endothelial cells is mediated through NF-kappaB and c-Jun NH2-terminal kinase pathway and prevented by PI3K/Akt/eNOS pathway. , 2006, Cellular signalling.

[27]  K. Lindpaintner,et al.  Risk of Coronary Artery Disease Associated With Polymorphism of the Cytochrome P450 Epoxygenase CYP2J2 , 2004, Circulation.

[28]  M. Meydani,et al.  Green tea catechins inhibit VEGF‐induced angiogenesis in vitro through suppression of VE‐cadherin phosphorylation and inactivation of Akt molecule , 2003, International journal of cancer.

[29]  S. Rafii,et al.  Recruitment of Stem and Progenitor Cells from the Bone Marrow Niche Requires MMP-9 Mediated Release of Kit-Ligand , 2002, Cell.

[30]  J. Isner,et al.  Endothelial progenitor cells for vascular regeneration. , 2002, Journal of hematotherapy & stem cell research.

[31]  M. Meydani,et al.  Green Tea Catechins and Vitamin E Inhibit Angiogenesis of Human Microvascular Endothelial Cells Through Suppression of IL-8 Production , 2001, Nutrition and cancer.

[32]  R. Busse,et al.  Cytochrome P450 2C is an EDHF synthase in coronary arteries , 1999, Nature.

[33]  M. Schwartzman,et al.  Renal cytochrome P450-related arachidonate metabolite inhibits (Na+ + K+)ATPase , 1985, Nature.

[34]  Yizhi Liu,et al.  Endothelial progenitor cells (EPCs) mobilized and activated by neurotrophic factors may contribute to pathologic neovascularization in diabetic retinopathy. , 2010, The American journal of pathology.

[35]  M. Jiménez-Navarro,et al.  Endothelial progenitor cells in cell-based therapy for cardiovascular disease. , 2008, Cellular and molecular biology.